triazoles has been researched along with Depression in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (17.39) | 18.7374 |
| 1990's | 13 (28.26) | 18.2507 |
| 2000's | 6 (13.04) | 29.6817 |
| 2010's | 14 (30.43) | 24.3611 |
| 2020's | 5 (10.87) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, D; Baldinotti, R; Fetter, J; Fronza, MG; Nogueira, CW; Praticò, D; Rosa, SG; Sacramento, M; Savegnago, L | 1 |
| Cully, M | 1 |
| Duan, HC; Gan, Y; Hu, JP; Hu, YC; Liang, L; Liu, W; Liu, XY; Luo, Q; Peng, LX; Shi, HB; Sun, X; Wan, H; Zhao, G | 1 |
| Jiang, Z; Khalid, A; Li, H; Liu, D; Pan, F; Wang, R; Wang, W; Zhu, Z | 1 |
| Bhatti, R; Gumede, N; Kaur, J; Kisten, P; Kumar, V; Rani, A; Singh, A; Singh, G; Singh, P | 1 |
| Cornil, CA; Dalla, C; de Bournonville, C; Kokras, N; Papasava, D; Pastromas, N | 1 |
| Chai, HH; Chen, GZ; Chen, WX; Chen, YS; Fu, XC; Guo, YW; Li, SP; Ma, L; Song, MY; Sun, HT; Tan, MX | 1 |
| Dev, KK; Doucet, MV; Harkin, A; Levine, H | 1 |
| Alves, D; de Gomes, MG; Donato, F; Goes, AT; Jesse, CR; Savegnago, L; Seus, N | 1 |
| Fraser, K | 1 |
| Bahi, A; Sadek, B; Schwed, JS; Stark, H; Walter, M | 1 |
| Bowman, M; Bruner, D; DeMichele, A; Farrar, JT; Mao, JJ; Seluzicki, C; Xie, SX; Zee, J | 1 |
| Hagel, D; Herbet, M; Izdebska, M; Jagiello-Wójtowicz, E; Kędzierska, E; Kosiek, S; Kuśmierz, E; Orzelska-Górka, J; Paneth, A; Piątkowska-Chmiel, I; Plech, T; Wujec, M | 1 |
| Amadori, D; Burris, H; Comarella, L; De Boer, R; Dowsett, M; Ejlertsen, B; Gnant, M; Hart, L; Jonat, W; McIntyre, K; O'Shaughnessy, J; Poggio, S; Pritchard, KI; Salomon, H; Smith, I; Wamil, B; Yardley, D | 1 |
| Kelly, BD | 1 |
| Liu, YJ; Meng, FT; Ni, RJ; Zhang, Z; Zhao, J; Zhou, JN | 1 |
| Möhler, H | 1 |
| Hozumi, Y; Ohashi, Y; Ohsumi, S; Shimozuma, K; Suemasu, K; Takehara, M; Takei, H | 1 |
| Engin, E; Liu, J; Rudolph, U | 1 |
| Castañeda, G; Muñoz, L; Rodríguez, J | 1 |
| Bottonari, KA; Dougherty, DD; Fava, M; Fischman, AJ; Gresham, RL; Mischoulon, D; Sonawalla, SB | 1 |
| HOZUMI, M; SUGIMURA, T | 1 |
| Avila, A; Bello, J; Cardona, X; Maho, P; Martin-Baranera, M; Sastre, F | 1 |
| Costentin, J; El Yacoubi, M; Vaugeois, JM | 1 |
| Fallowfield, L; Howell, A; Hutton, S; Jenkins, V; Shilling, V | 1 |
| Blatman-Jan, G; Dremencov, E; Kinor, N; Newman, ME; Overstreet, DH; Schindler, CJ; Yadid, G | 1 |
| DeMartinis, NA; Rickels, K; Schweizer, E | 1 |
| Callahan, AM; Ketter, TA; Post, R | 1 |
| Benazzi, F | 1 |
| Levenstein, S; Rama, D | 1 |
| Beeson, MS; Gaffney, PN; Schuckman, HA | 1 |
| Aranda-Michel, J; Balistreri, WF; Bejarano, PA; Ee, LC; Khan, CM; Koehler, A; Luxon, BA; Poulos, JE; Weber, FL | 1 |
| Benfield, P; Wilde, MI | 1 |
| Roberts-Thompson, IC; Schrader, GD | 1 |
| Berkowitz, DV; Conrad, C; McDannold, M; Scharf, MB; Spinner, O; Stover, R; Zaretsky, N | 1 |
| Gibson, JP; Kociba, GJ; Yarrington, JT | 1 |
| Egilmez, S; Itil, TM; Marasa, J; Polvan, N; Saletu, B | 1 |
| Vinar, O | 1 |
| Udabe, RU | 1 |
| Amin, M; Ban, TA; Klingner, A | 1 |
| Brown, GL; Green, RL; Martin, RM | 1 |
| Amin, M; Ban, TA; Bronheim, LA; Galvan, L; Klingner, A; Lehmann, HE; Nair, NP; Vergara, L; Zoch, C | 1 |
| Knobel, M | 1 |
5 review(s) available for triazoles and Depression
| Article | Year |
|---|---|
The Advances of the Structure and Function of Indoleamine 2, 3- dioxygenase 1 and Its Inhibitors.
Topics: Alzheimer Disease; Antineoplastic Agents; Depression; Drug Design; Enzyme Inhibitors; Gene Expression; Histocompatibility, Maternal-Fetal; Humans; Imidazoles; Immune Tolerance; Indoleamine-Pyrrole 2,3,-Dioxygenase; Indoles; Neoplasms; Neuroprotective Agents; Signal Transduction; Structure-Activity Relationship; Triazoles; Tumor Escape | 2020 |
The GABA system in anxiety and depression and its therapeutic potential.
Topics: Antidepressive Agents; Anxiety; Depression; GABA Agonists; gamma-Aminobutyric Acid; Humans; Neural Pathways; Pyridazines; Receptors, GABA; Triazoles | 2012 |
α2-containing GABA(A) receptors: a target for the development of novel treatment strategies for CNS disorders.
Topics: Alcoholism; Animals; Anxiety; Central Nervous System Diseases; Chronic Pain; Cognition Disorders; Depression; GABA-A Receptor Agonists; Humans; Polymorphism, Genetic; Pyridazines; Receptors, GABA-A; Schizophrenia; Substance-Related Disorders; Triazoles | 2012 |
Fluoxetine. A pharmacoeconomic review of its use in depression.
Topics: Antidepressive Agents, Tricyclic; Depression; Fluoxetine; Health Care Costs; Humans; Piperazines; Quality of Life; Selective Serotonin Reuptake Inhibitors; Triazoles | 1998 |
Clinical experience with a new psychotropic drug, trazodone: a review of literature.
Topics: Amitriptyline; Antidepressive Agents; Anxiety; Chlordiazepoxide; Clinical Trials as Topic; Depression; Diazepam; Drug Tolerance; Humans; Imipramine; Piperazines; Pyridines; Schizophrenia; Tranquilizing Agents; Triazoles | 1973 |
12 trial(s) available for triazoles and Depression
| Article | Year |
|---|---|
Electroacupuncture for fatigue, sleep, and psychological distress in breast cancer patients with aromatase inhibitor-related arthralgia: a randomized trial.
Topics: Aged; Anastrozole; Androstadienes; Anxiety; Aromatase Inhibitors; Arthralgia; Breast Neoplasms; Depression; Electroacupuncture; Fatigue; Female; Humans; Letrozole; Middle Aged; Nitriles; Quality of Life; Sleep Wake Disorders; Stress, Psychological; Treatment Outcome; Triazoles | 2014 |
Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Arthralgia; Breast Neoplasms; Chemotherapy, Adjuvant; Depression; Disease-Free Survival; Dyspnea; Female; Hot Flashes; Humans; Hypertension; Letrozole; Lymphatic Metastasis; Mastectomy; Middle Aged; Myalgia; Neoplasm Staging; Nitriles; Postmenopause; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Triazoles | 2017 |
Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04 (N-
Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Depression; Female; Humans; Maintenance Chemotherapy; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Quality of Life; Stress, Psychological; Surveys and Questionnaires; Tamoxifen; Treatment Outcome; Triazoles | 2012 |
Does nefazodone improve both depression and Parkinson disease? A pilot randomized trial.
Topics: Aged; Analysis of Variance; Depression; Female; Humans; Male; Middle Aged; Parkinson Disease; Pilot Projects; Piperazines; Prospective Studies; Single-Blind Method; Triazoles | 2003 |
Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study.
Topics: Affect; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Breast Neoplasms; Cognition Disorders; Depression; England; Estrogens; Female; Humans; Memory Disorders; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Nitriles; Personality Inventory; Pilot Projects; Reaction Time; Self-Assessment; Tamoxifen; Triazoles; Verbal Learning | 2004 |
An open-label trial of nefazodone in high comorbidity panic disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Comorbidity; Depression; Depressive Disorder; Female; Humans; Male; Middle Aged; Panic Disorder; Piperazines; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome; Triazoles | 1996 |
Evaluation of sleep architecture and cyclic alternating pattern rates in depressed insomniac patients treated with nefazodone hydrochloride.
Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Female; Humans; Male; Periodicity; Piperazines; Placebos; Polysomnography; Single-Blind Method; Sleep; Sleep Initiation and Maintenance Disorders; Sleep, REM; Substance Withdrawal Syndrome; Triazoles | 1999 |
Clinical experience with a new psychotropic drug, trazodone: a review of literature.
Topics: Amitriptyline; Antidepressive Agents; Anxiety; Chlordiazepoxide; Clinical Trials as Topic; Depression; Diazepam; Drug Tolerance; Humans; Imipramine; Piperazines; Pyridines; Schizophrenia; Tranquilizing Agents; Triazoles | 1973 |
Trazodone in the treatment of affective disorders.
Topics: Adjustment Disorders; Adult; Antidepressive Agents; Clinical Trials as Topic; Depression; Female; Humans; Male; Middle Aged; Piperazines; Placebos; Psychiatric Status Rating Scales; Pyridines; Time Factors; Triazoles | 1973 |
Double-blind, noncrossover study of imipramine and A-10749.
Topics: Administration, Oral; Adult; Aged; Antidepressive Agents; Clinical Trials as Topic; Depression; Evaluation Studies as Topic; Female; Humans; Imipramine; Ketones; Male; Middle Aged; Psychiatric Status Rating Scales; Time Factors; Triazoles | 1972 |
Differential effects of trazodone in depressed, schizophrenic and geriatric patients.
Topics: Adult; Antidepressive Agents; Clinical Trials as Topic; Dementia; Depression; Female; Humans; Male; Middle Aged; Neurocognitive Disorders; Piperazines; Psychiatric Status Rating Scales; Pyridines; Schizophrenia; Time Factors; Triazoles | 1974 |
The use of trazodone in psychosomatic medicine.
Topics: Adult; Antidepressive Agents; Asthma; Biliary Tract Diseases; Clinical Trials as Topic; Colitis; Coronary Disease; Depression; Female; Gastritis; Humans; Liver Diseases; Male; Middle Aged; Piperazines; Placebos; Psychophysiologic Disorders; Pyridines; Triazoles; Urologic Diseases | 1974 |
30 other study(ies) available for triazoles and Depression
| Article | Year |
|---|---|
Beneficial effects of QTC-4-MeOBnE in an LPS-induced mouse model of depression and cognitive impairments: The role of blood-brain barrier permeability, NF-κB signaling, and microglial activation.
Topics: Acetylcholinesterase; Animals; Blood-Brain Barrier; Cognitive Dysfunction; Depression; Lipopolysaccharides; Mice; Microglia; NF-kappa B; Permeability; Quinolines; Triazoles | 2022 |
Can anti-inflammatory strategies light up the dim depression pipeline?
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Depression; Depressive Disorder; Drug Discovery; Humans; Inflammation; Pyridines; Triazoles | 2020 |
Inhibiting Brd4 alleviated PTSD-like behaviors and fear memory through regulating immediate early genes expression and neuroinflammation in rats.
Topics: Animals; Anxiety; Azepines; Brain Chemistry; Cues; Dendritic Spines; Depression; Encephalitis; Fear; Gene Expression Regulation; Genes, Immediate-Early; Male; Memory; Motor Activity; Nuclear Proteins; Rats; Rats, Wistar; Stress Disorders, Post-Traumatic; Transcription Factors; Triazoles | 2021 |
1H-1,2,3-triazole grafted tacrine-chalcone conjugates as potential cholinesterase inhibitors with the evaluation of their behavioral tests and oxidative stress in mice brain cells.
Topics: Acetylcholinesterase; Animals; Anxiety; Brain; Butyrylcholinesterase; Chalcones; Cholinesterase Inhibitors; Depression; Dose-Response Relationship, Drug; Mice; Molecular Docking Simulation; Molecular Structure; Oxidative Stress; Rats; Structure-Activity Relationship; Tacrine; Triazoles | 2021 |
Sex differences in behavioral and neurochemical effects of gonadectomy and aromatase inhibition in rats.
Topics: Animals; Antidepressive Agents; Aromatase; Aromatase Inhibitors; Behavior, Animal; Brain; Castration; Corticosterone; Depression; Female; Hippocampus; Letrozole; Male; Nitriles; Orchiectomy; Ovariectomy; Prefrontal Cortex; Rats; Rats, Wistar; Serotonin; Sex Characteristics; Testosterone; Triazoles | 2018 |
The chemokine CXCL1 and its receptor CXCR2 contribute to chronic stress-induced depression in mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Apoptosis; Brain-Derived Neurotrophic Factor; Chemokine CXCL1; Depression; Fluoxetine; Glycogen Synthase Kinase 3 beta; Hippocampus; Male; Mice; Mice, Inbred C57BL; Neuronal Plasticity; Phenylurea Compounds; Receptors, Interleukin-8B; Stress, Psychological; Thiazoles; Triazoles; Urea | 2019 |
Small-molecule inhibitors at the PSD-95/nNOS interface have antidepressant-like properties in mice.
Topics: Animals; Antidepressive Agents; Chlorophenols; Depression; Disks Large Homolog 4 Protein; Guanylate Kinases; Hindlimb Suspension; Male; Membrane Proteins; Mice; Motor Activity; Nitric Oxide Synthase Type I; Triazoles | 2013 |
Involvement of the dopaminergic and serotonergic systems in the antidepressant-like effect caused by 4-phenyl-1-(phenylselanylmethyl)-1,2,3-triazole.
Topics: Animals; Antidepressive Agents; Catalase; Cerebral Cortex; Chromatography, High Pressure Liquid; Depression; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Glutathione Transferase; Hippocampus; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Organoselenium Compounds; Serotonin; Time Factors; Toxicity Tests, Acute; Triazoles | 2013 |
72nd annual meeting of the American Academy of Dermatology.
Topics: Antifungal Agents; Attention Deficit Disorder with Hyperactivity; Boron Compounds; Botulinum Toxins, Type A; Bridged Bicyclo Compounds, Heterocyclic; Brimonidine Tartrate; Depression; Dermatitis, Atopic; Food Hypersensitivity; Humans; Immunologic Factors; Ivermectin; Phosphodiesterase Inhibitors; Phototherapy; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quinoxalines; Skin Diseases; Societies, Medical; Thalidomide; Triazoles; United States | 2014 |
Anxiolytic and antidepressant-like activities of the novel and potent non-imidazole histamine H₃ receptor antagonist ST-1283.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Depression; Dose-Response Relationship, Drug; Histamine H3 Antagonists; Humans; Male; Mice; Mice, Inbred C57BL; Pyridines; Receptors, Histamine H3; Structure-Activity Relationship; Triazoles | 2014 |
Preliminary Pharmacological Screening of Some Thiosemicarbazide, s-triazole, and Thiadiazole Derivatives.
Topics: Analgesics; Animals; Anxiety; Body Temperature; Central Nervous System Agents; Depression; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Mice; Molecular Structure; Motor Activity; Nociceptive Pain; Seizures; Semicarbazides; Sleep; Thiadiazoles; Triazoles | 2016 |
Do new-generation antidepressants work?
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Fluoxetine; Humans; Paroxetine; Piperazines; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2008 |
Inhibition of oestrogen biosynthesis induces mild anxiety in C57BL/6J ovariectomized female mice.
Topics: Animals; Anxiety; Aromatase Inhibitors; Depression; Disease Models, Animal; Estradiol; Female; Hippocampus; Humans; Immobility Response, Tonic; Learning; Letrozole; Maze Learning; Memory; Mice; Mice, Inbred C57BL; Motor Activity; Nitriles; Ovariectomy; Triazoles | 2011 |
Rapid determination of letrozole, citalopram and their metabolites by high performance liquid chromatography-fluorescence detection in urine: Method validation and application to real samples.
Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents; Breast Neoplasms; Chromatography, High Pressure Liquid; Citalopram; Depression; Drug Monitoring; Female; Humans; Letrozole; Limit of Detection; Middle Aged; Nitriles; Reproducibility of Results; Spectrometry, Fluorescence; Triazoles | 2013 |
An open pilot study of nefazodone in depression with anger attacks: relationship between clinical response and receptor binding.
Topics: Adult; Anger; Antidepressive Agents, Second-Generation; Binding Sites; Brain; Depression; Female; Humans; Male; Pilot Projects; Piperazines; Receptors, Dopamine; Receptors, Serotonin; Severity of Illness Index; Surveys and Questionnaires; Thalamus; Tomography, Emission-Computed; Triazoles | 2002 |
Studies on the mechanism of catalase depression by toxohormone, with the aid of allylisopropylacetamide, allylisopropylacetylcarbamide, and 3-amino-1,2,4-triazole.
Topics: Allylisopropylacetamide; Amides; Amitrole; Azoles; Catalase; Depression; Depressive Disorder; Endotoxins; Hypnotics and Sedatives; Neoplasms; Triazoles; Urea | 1962 |
Adenosine A2A receptors and depression.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Antidepressive Agents; Behavior, Animal; Caffeine; Depression; Disease Models, Animal; Dopamine Antagonists; Drug Interactions; Haloperidol; Mice; Mice, Knockout; Motor Activity; Neurotransmitter Agents; Parkinsonian Disorders; Purines; Pyrimidines; Receptor, Adenosine A2A; Triazines; Triazoles | 2003 |
Hyperfunctionality of serotonin-2C receptor-mediated inhibition of accumbal dopamine release in an animal model of depression is reversed by antidepressant treatment.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Depression; Desipramine; Disease Models, Animal; Dopamine; Extracellular Space; Male; Microdialysis; Models, Animal; Nucleus Accumbens; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Spiro Compounds; Staining and Labeling; Sulfonamides; Time Factors; Triazoles | 2005 |
Nefazodone relief of alprazolam interdose dysphoria: a potential therapeutic benefit of 3A3/4 inhibition.
Topics: Alprazolam; Antidepressive Agents, Second-Generation; Anxiety; Cytochrome P-450 Enzyme Inhibitors; Depression; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Middle Aged; Piperazines; Treatment Outcome; Triazoles | 1996 |
[Nefazodon (Nefadar)--a new dual serotoninergic antidepressant. Introductory press conference: "Nefazodone--new perspectives in antidepressive therapy." 25-26 April 1997].
Topics: Antidepressive Agents, Second-Generation; Depression; Humans; Piperazines; Triazoles | 1997 |
Parkinson's disease worsened by nefazodone.
Topics: Aged; Antidepressive Agents, Second-Generation; Depression; Humans; Male; Parkinson Disease; Parkinson Disease, Secondary; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles | 1997 |
[Sleep-profile of a 72-year-old depressive female patient. Depression and sleep disorders. Significance--causes--treatment].
Topics: Aged; Antidepressive Agents, Second-Generation; Depression; Female; Humans; Piperazines; Sleep Initiation and Maintenance Disorders; Sleep, REM; Triazoles | 1998 |
[Depression and sleep disorders. Progress in antidepressive therapy with nefazodone].
Topics: Antidepressive Agents, Second-Generation; Depression; Humans; Piperazines; Sleep Initiation and Maintenance Disorders; Triazoles | 1998 |
Depression in general practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Depression; Female; Humans; Male; Middle Aged; South Africa; Triazoles | 1998 |
Nefazodone overdose.
Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Drug Overdose; Female; Humans; Piperazines; Triazoles | 1998 |
Nefazodone-induced liver failure: report of three cases.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Depression; Female; Humans; Liver; Liver Failure, Acute; Middle Aged; Piperazines; Triazoles | 1999 |
Adverse effect of nefazodone: hepatitis.
Topics: Adult; Antidepressive Agents, Second-Generation; Chemical and Drug Induced Liver Injury; Depression; Humans; Male; Phobic Disorders; Piperazines; Triazoles | 1999 |
Thrombocytopenia in rats and dogs administered the antidepressant compound MDL-19,660.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Blood Platelets; Bone Marrow; Bone Marrow Cells; Cell Count; Depression; Dogs; Dose-Response Relationship, Drug; Female; Leukocyte Count; Male; Megakaryocytes; Platelet Count; Rats; Rats, Inbred Strains; Thrombocytopenia; Triazoles | 1991 |
Anxiolytic effects of a new triazolobenzodiazepine, U-31,889.
Topics: Adult; Animals; Anxiety; Behavior, Animal; Benzodiazepinones; Blood Circulation; Central Nervous System; Computers; Depression; Dogs; Electroencephalography; Female; Flurazepam; Humans; Hypnotics and Sedatives; Leukocyte Count; Male; Middle Aged; Movement Disorders; Respiration; Seizures; Sleep; Sleep Initiation and Maintenance Disorders; Tranquilizing Agents; Triazoles | 1973 |
Introductory remarks: new agents in psychiatry.
Topics: Antidepressive Agents; Anxiety Disorders; Depression; Humans; Mental Disorders; Piperazines; Pyridines; Schizophrenia; Triazoles; United States; United States Food and Drug Administration | 1973 |